183 related articles for article (PubMed ID: 23557166)
1. First trimester PAPP-A levels correlate with sFlt-1 levels longitudinally in pregnant women with and without preeclampsia.
Saxena AR; Seely EW; Rich-Edwards JW; Wilkins-Haug LE; Karumanchi SA; McElrath TF
BMC Pregnancy Childbirth; 2013 Apr; 13():85. PubMed ID: 23557166
[TBL] [Abstract][Full Text] [Related]
2. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.
Park HJ; Kim SH; Jung YW; Shim SS; Kim JY; Cho YK; Farina A; Zanello M; Lee KJ; Cha DH
BMC Pregnancy Childbirth; 2014 Jan; 14():35. PubMed ID: 24444293
[TBL] [Abstract][Full Text] [Related]
3. Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.
Rizos D; Eleftheriades M; Karampas G; Rizou M; Haliassos A; Hassiakos D; Vitoratos N
Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):225-30. PubMed ID: 24035323
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of sFlt-1, PlGF, sFlt-1/PlGF ratio and PAPP-A for late-onset preeclampsia and IUGR between 32 and 37 weeks of pregnancy.
Birdir C; Droste L; Fox L; Frank M; Fryze J; Enekwe A; Köninger A; Kimmig R; Schmidt B; Gellhaus A
Pregnancy Hypertens; 2018 Apr; 12():124-128. PubMed ID: 29674192
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Predictive Information From Biomarkers Added to Clinical Models of Preeclampsia: Consideration of PAPP-A2, Activin A, and sFlt-1:PlGF Ratio.
Daskalopoulou SS; Labos C; Kuate Defo A; Cooke AB; Kalra B; Kumar A; Mantzoros CS
Can J Cardiol; 2024 Mar; 40(3):422-430. PubMed ID: 38787345
[TBL] [Abstract][Full Text] [Related]
6. First trimester serum angiogenic and anti-angiogenic factors in women with chronic hypertension for the prediction of preeclampsia.
Nzelu D; Biris D; Karampitsakos T; Nicolaides KK; Kametas NA
Am J Obstet Gynecol; 2020 Apr; 222(4):374.e1-374.e9. PubMed ID: 31705883
[TBL] [Abstract][Full Text] [Related]
7. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Preeclampsia in Nulliparous Women according to First Trimester Maternal Factors and Serum Markers.
Pihl K; Sørensen S; Stener Jørgensen F
Fetal Diagn Ther; 2020; 47(4):277-283. PubMed ID: 31622970
[TBL] [Abstract][Full Text] [Related]
9. [Influences on Placental Growth Factor (PlGF) and Soluble fms-like Tyrosine Kinase-1 (sFlt-1) Concentration Levels at the Time of First Trimester Screening].
von See J; Limperger V; Pecks U; Eckmann-Scholz C
Z Geburtshilfe Neonatol; 2016 Aug; 220(4):166-72. PubMed ID: 27135751
[TBL] [Abstract][Full Text] [Related]
10. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
Leaños-Miranda A; Campos-Galicia I; Berumen-Lechuga MG; Molina-Pérez CJ; García-Paleta Y; Isordia-Salas I; Ramírez-Valenzuela KL
J Rheumatol; 2015 Jul; 42(7):1141-9. PubMed ID: 25979720
[TBL] [Abstract][Full Text] [Related]
11. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction.
Vatten LJ; Åsvold BO; Eskild A
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1388-94. PubMed ID: 22882089
[TBL] [Abstract][Full Text] [Related]
12. Serum placental growth factor and fms-like tyrosine kinase 1 during first trimester in Chinese women with pre-eclampsia--a case-control study.
Wa Law L; Sahota DS; Chan LW; Chen M; Lau TK; Leung TY
J Matern Fetal Neonatal Med; 2011 Jun; 24(6):808-11. PubMed ID: 21534854
[TBL] [Abstract][Full Text] [Related]
13. Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant women.
Forest JC; Thériault S; Massé J; Bujold E; Giguère Y
Clin Chem Lab Med; 2014 Aug; 52(8):1169-78. PubMed ID: 24535301
[TBL] [Abstract][Full Text] [Related]
14. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
[TBL] [Abstract][Full Text] [Related]
15. Circulating angiogenic factors and the risk of preeclampsia.
Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
[TBL] [Abstract][Full Text] [Related]
16. Association of first-trimester angiogenic factors with placental histological findings in late-onset preeclampsia.
Triunfo S; Crovetto F; Crispi F; Rodriguez-Sureda V; Dominguez C; Nadal A; Peguero A; Gratacos E; Figueras F
Placenta; 2016 Jun; 42():44-50. PubMed ID: 27238713
[TBL] [Abstract][Full Text] [Related]
17. Maternal circulating angiogenic factors in twin and singleton pregnancies.
Faupel-Badger JM; McElrath TF; Lauria M; Houghton LC; Lim KH; Parry S; Cantonwine D; Lai G; Karumanchi SA; Hoover RN; Troisi R
Am J Obstet Gynecol; 2015 May; 212(5):636.e1-8. PubMed ID: 25434840
[TBL] [Abstract][Full Text] [Related]
18. The role of angiogenic and antiangiogenic factors in the second trimester in the prediction of preeclampsia in pregnant women with type 1 diabetes.
Holmes VA; Young IS; Patterson CC; Maresh MJ; Pearson DW; Walker JD; McCance DR;
Diabetes Care; 2013 Nov; 36(11):3671-7. PubMed ID: 23920083
[TBL] [Abstract][Full Text] [Related]
19. Ultra-high sensitive C-reactive protein during normal pregnancy and in preeclampsia: a pilot study.
Raio L; Bersinger NA; Malek A; Schneider H; Messerli FH; Hürter H; Rimoldi SF; Baumann MU
J Hypertens; 2019 May; 37(5):1012-1017. PubMed ID: 30882594
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort.
Villa PM; Hämäläinen E; Mäki A; Räikkönen K; Pesonen AK; Taipale P; Kajantie E; Laivuori H
BMC Pregnancy Childbirth; 2013 May; 13():110. PubMed ID: 23663420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
